No tax




Security policy (edit with Customer reassurance module)


Delivery policy (edit with Customer reassurance module)


Return policy (edit with Customer reassurance module)

Dosage Form

White crystalline powder, odorless.

pharmachologic effect

Streptocide is an antimicrobial bacteriostatic agent, sulfanilamide. The mechanism of action is due to competitive antagonism with para-aminobenzoic acid (PUNK), inhibition of dihydropteroate synthase, a violation of the synthesis of tetrahydrofolic acid, necessary for the synthesis of purines and pyrimidips. Active against gram-positive and gram-negative cocci, Escherichia coli. Shigella spp., Vibrio cholerae, Clostridium perfringens, Bacillus anthracis, Corynebacterium diphtheriae, Yersinia pestis. Chlamydia spp., Actinomyces israelii. Toxoplasma gondii. When applied to the skin, it promotes rapid healing of wounds and epithelization of erosions.

Side effects

In case of hypersensitivity to sulfa drugs, allergic reactions are possible, the development of which requires immediate discontinuation of the drug. In addition, possible headache, dizziness, nausea, vomiting, dyspepsia, cyanosis, leukopenia, agranulocytosis, crystalluria. If any of the side effects indicated in the instruction are aggravated, or you have noticed any other side effects that are not indicated in the instruction, inform your doctor.

Sales features


Special conditions

Abundant alkaline drinking is recommended during therapy. If necessary, prescribe antimicrobial drugs inside.

Influence on ability to steer vehicles, mechanisms:

Considering the side effects of the drug, care should be taken when driving vehicles and machinery.


As part of complex therapy: purulent wounds, infected burns (I-II degree) and other purulent-inflammatory processes of soft tissues.


- hypersensitivity to sulfonamides;

- liver or kidney failure;

- diseases of the hematopoietic system;

- inhibition of bone marrow hematopoiesis;

- anemia;

- chronic heart failure;

- congenital deficiency of glucose-6-phosphate dehydrogenase;

- azotemia;

- porphyria;

- thyrotoxicosis;

- pregnancy and breastfeeding period.



Pregnancy and lactation:

The drug is contraindicated during pregnancy and during breastfeeding.

Drug interaction

Myelotoxic drugs increase the hematotoxicity of the drug.


Externally, applied directly to the affected surface (in the form of a powder for external use). Ligation produced in 1-2 days. Maximum doses for adults: single dose - 5 g, daily dose - 15 g. Children over 3 years old - 300 mg - single dose, daily dose 300 mg.


Symptoms: nausea, vomiting, intestinal colic, dizziness, headache, drowsiness, depression, fainting, confusion, blurred vision, fever, hematuria, crystalluria; with prolonged overdose - thrombocytopenia, leukopenia, megaloblastic anemia, jaundice.

Treatment: drink plenty of water; in case of accidental ingestion - gastric lavage.

25 Items